Biotech · Private company

LumiraDx UK Limited

Track this companyFree. Adds LumiraDx UK Limited to your Dealase workspace and tells you when its record changes.

Clinical trials80 recruiting or active

Pipeline programs16From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline16

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Combo TestCOMPLETED · started May 4, 2023ClinicalTrials.gov NCT05787444 · fetched Nov 12, 2026
POC Performance Evaluation of LumiraDx SARS-CoV-2 Ag Ultra and SARS-CoV-2 & Flu A/B Tests.COMPLETED · started Feb 9, 2023ClinicalTrials.gov NCT05728970 · fetched Nov 12, 2026
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA TestCOMPLETED · started Jun 30, 2022ClinicalTrials.gov NCT05506618 · fetched Nov 12, 2026
Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 AssessmentCOMPLETED · started Jan 4, 2022ClinicalTrials.gov NCT05268939 · fetched Nov 12, 2026
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab TestCOMPLETED · started Jul 9, 2020ClinicalTrials.gov NCT04597047 · fetched Nov 12, 2026
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag TestCOMPLETED · started Jun 26, 2020ClinicalTrials.gov NCT04557046 · fetched Nov 12, 2026
Evaluation of the LumiraDx Point of Care D-Dimer and CRP TestsCOMPLETED · started Apr 20, 2020ClinicalTrials.gov NCT04375982 · fetched Nov 12, 2026
Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing SitesCOMPLETED · started Feb 6, 2020ClinicalTrials.gov NCT04288921 · fetched Nov 12, 2026